These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27228213)

  • 1. High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC).
    Marescotti D; Gonzalez Suarez I; Acali S; Johne S; Laurent A; Frentzel S; Hoeng J; Peitsch MC
    J Vis Exp; 2016 May; (111):. PubMed ID: 27228213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems biology approach for evaluating the biological impact of environmental toxicants in vitro.
    Gonzalez-Suarez I; Sewer A; Walker P; Mathis C; Ellis S; Woodhouse H; Guedj E; Dulize R; Marescotti D; Acali S; Martin F; Ivanov NV; Hoeng J; Peitsch MC
    Chem Res Toxicol; 2014 Mar; 27(3):367-76. PubMed ID: 24428674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and 
    Hashizume T; Ishikawa S; Matsumura K; Ito S; Fukushima T
    Toxicol Rep; 2023; 10():281-292. PubMed ID: 36876026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Tobacco Heating System 2.2. Part 3: Influence of the tobacco blend on the formation of harmful and potentially harmful constituents of the Tobacco Heating System 2.2 aerosol.
    Schaller JP; Pijnenburg JPM; Ajithkumar A; Tricker AR
    Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S48-S58. PubMed ID: 27793747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of electronic cigarette formulations and aerosols for harmful and potentially harmful constituents (HPHCs) typically derived from combustion.
    Wagner KA; Flora JW; Melvin MS; Avery KC; Ballentine RM; Brown AP; McKinney WJ
    Regul Toxicol Pharmacol; 2018 Jun; 95():153-160. PubMed ID: 29567331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmful and Potentially Harmful Constituents in E-Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS).
    Reilly SM; Cheng T; Feng C; Walters MJ
    Chem Res Toxicol; 2024 Jul; 37(7):1155-1170. PubMed ID: 38924487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air.
    Tayyarah R; Long GA
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):704-10. PubMed ID: 25444997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol.
    Schaller JP; Keller D; Poget L; Pratte P; Kaelin E; McHugh D; Cudazzo G; Smart D; Tricker AR; Gautier L; Yerly M; Reis Pires R; Le Bouhellec S; Ghosh D; Hofer I; Garcia E; Vanscheeuwijck P; Maeder S
    Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S27-S47. PubMed ID: 27720919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols.
    Flora JW; Meruva N; Huang CB; Wilkinson CT; Ballentine R; Smith DC; Werley MS; McKinney WJ
    Regul Toxicol Pharmacol; 2016 Feb; 74():1-11. PubMed ID: 26617410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Youth and adult understanding of public displays of information about harmful constituents in cigarette smoke.
    Venrick SJ; Margolis KA; Bernat JK; Pepper JK; Nonnemaker JM; Eggers ME
    Prev Med; 2023 Apr; 169():107458. PubMed ID: 36813248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes.
    Jaccard G; Tafin Djoko D; Moennikes O; Jeannet C; Kondylis A; Belushkin M
    Regul Toxicol Pharmacol; 2017 Nov; 90():1-8. PubMed ID: 28818540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. I. Inhalation exposure, clinical pathology and histopathology.
    Phillips BW; Schlage WK; Titz B; Kogel U; Sciuscio D; Martin F; Leroy P; Vuillaume G; Krishnan S; Lee T; Veljkovic E; Elamin A; Merg C; Ivanov NV; Peitsch MC; Hoeng J; Vanscheeuwijck P
    Food Chem Toxicol; 2018 Jun; 116(Pt B):388-413. PubMed ID: 29654848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. II. Systems toxicology assessment.
    Titz B; Kogel U; Martin F; Schlage WK; Xiang Y; Nury C; Dijon S; Baumer K; Peric D; Bornand D; Dulize R; Phillips B; Leroy P; Vuillaume G; Lebrun S; Elamin A; Guedj E; Trivedi K; Ivanov NV; Vanscheeuwijck P; Peitsch MC; Hoeng J
    Food Chem Toxicol; 2018 May; 115():284-301. PubMed ID: 29545142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette.
    Gonzalez-Suarez I; Martin F; Marescotti D; Guedj E; Acali S; Johne S; Dulize R; Baumer K; Peric D; Goedertier D; Frentzel S; Ivanov NV; Mathis C; Hoeng J; Peitsch MC
    Chem Res Toxicol; 2016 Jan; 29(1):3-18. PubMed ID: 26651182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between endogenous harmful components in mainstream cigarette smoke and chemical constituents in tobacco leaves].
    Geng ZL; Zhang J; Ge YH; Xiang ZM; Cai K; Zhu XL; Li JX; Feng YG
    Ying Yong Sheng Tai Xue Bao; 2015 May; 26(5):1447-53. PubMed ID: 26571664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product.
    Iskandar AR; Mathis C; Martin F; Leroy P; Sewer A; Majeed S; Kuehn D; Trivedi K; Grandolfo D; Cabanski M; Guedj E; Merg C; Frentzel S; Ivanov NV; Peitsch MC; Hoeng J
    ALTEX; 2017; 34(1):23-48. PubMed ID: 27388676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from analysis for harmful and potentially harmful constituents (HPHCs) in tobacco products.
    Oldham MJ; DeSoi DJ; Rimmer LT; Wagner KA; Morton MJ
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):138-48. PubMed ID: 24973503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of novel tobacco heating product THP1.0. Part 6: A comparative in vitro study using contemporary screening approaches.
    Taylor M; Thorne D; Carr T; Breheny D; Walker P; Proctor C; Gaça M
    Regul Toxicol Pharmacol; 2018 Mar; 93():62-70. PubMed ID: 29080849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful and Potentially Harmful Constituents in the Filler and Smoke of Tobacco-Containing Tobacco Products.
    Cheng T; Reilly SM; Feng C; Walters MJ; Holman MR
    ACS Omega; 2022 Jul; 7(29):25537-25554. PubMed ID: 35910156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program.
    Smith MR; Clark B; Lüdicke F; Schaller JP; Vanscheeuwijck P; Hoeng J; Peitsch MC
    Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S17-S26. PubMed ID: 27450400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.